Growth Stage:
  • Nascent
  • Early
  • Growth
  • Mature
Companies with similar business models:

Meditect

www.meditect.com/en
Last updated: 10 May, 2022
Company Overview
Geographies Côte d'Ivoire, Cameroon, Senegal
Core Service Areas Track and Trace, Counterfeit Drug Detection, Marketplace and Fulfillment, Inventory Management
Founder(s) Arnaud Pourredon, Romain Renard
Founded 2017
Core Offerings
Meditect is a digital health platform, which digitizes actors of the medicine supply chain in sub-Saharan Africa (patients, pharmacies and pharmaceutical companies). The company's first product is a traceability solution used to assess the origin of any pharmaceutical product in Meditect’s database (the tool uses GS1 matrix for standards). Using this tool, patients can trace product origin, see product pricing, and identify nearby pharmacies. In addition, Meditect has deployed a subscription, fee-based software management tool for pharmacists offering a mobile first, online first and touch first approach to improve inventory management.
Funding & Key Investors
LBO France, Angel investors, French Public Bank of Investment (BPI France), Région Nouvelle-Aquitaine, Columbia University Challenge, EIT Health
Growth Stage:
  • Nascent
  • Early
  • Growth
  • Mature
Companies with similar business models:
Are you interested in companies like this?

Salient specilizes in connecting investors with innovators who are shaping the landscape of health tech in Africa.

Are you Meditect?
If you’re a representative of Meditect and want to update your information, contact us to submit a revision.